Predicted Change In 10 Year Cardiovascular Risk One Year After Initiation Of Bempedoic Acid Based Therapy

Table. Patient characteristics at pre-treatmenta Predicted change in 10-year cardiovascular risk, one year after Variable Total (N=960) initiation of bempedoic acid-based therapy in the MILOS study Age, years, mean (SD) 66.8 (10.2) Male, n (%) 661 (68.9)... More

Table. Patient characteristics at pre-treatmenta Predicted change in 10-year cardiovascular risk, one year after Variable Total (N=960) initiation of bempedoic acid-based therapy in the MILOS study Age, years, mean (SD) 66.8 (10.2) Male, n (%) 661 (68.9) Klaus G Parhofer1, Maurizio Averna2,3, Ioanna Gouni-Berthold4, Johan Wouter Konstantinos Jukema5, Richa Olesya Koskinas6, Chhabra7, Ajnakina7, Christian Becker7, Body mass index, kg/m2, mean (SD) 26.9 (4.0) Xavier Pintó8, Jeanine E Roeters van Lennep9, Thomas Stulnig10, Thomas Vanassche11, and Kausik K. Ray12 on behalf of the MILOS study group Systolic blood pressure, mmHg, mean (SD) 130.4 (16.2) 1Ludwig-Maximilians University Munich, LMU-Klinikum Medical Department 4 –Grosshadern, Munich, Germany; 2Department ProMISE – Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Diabetes mellitus, n (%) 166 (17.3) Specialties, University of Palermo, Palermo, Italy; 3Instituto di Biofisica, Italian National Rese Less